Oct
2026
Fiera Milano, Italy
Visit us
stand 20C65, Finished Dosage & Formulation
Zone

Shenzhen Mellow Hope Pharm Industrial Co., Ltd.

Exhibitor at CPHI Milan 2026
About Us

Email: [email protected] Tel: +86-755-82720498

Established in 2001, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. has specialized in exporting vaccines and biopharmaceuticals for 20+ years, serving Southeast Asia, South Asia, CIS, Latin America, and MENA. With strong CTD/ACTD dossier, we’ve registered and commercialized products in 30+ countries. In 2017, we founded Urihk Pharmaceutical in India, launching local manufacturing and distribution in 2018 to boost supply and regulatory agility in South Asia.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Distributor/Import Export
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Finished Formulation products Distributor/Buyer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20C65, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Meningococcal Polysaccharide Vaccine (Group A/C/Y/W135)

    Product Meningococcal Polysaccharide Vaccine (Group A/C/Y/W135)

    [Dosage Form]: Freeze-dried powder for Injection [Indication]: The vaccine is indicated for active immunization against invasive meningococcal disease caused by Neisseria meningitis group A, group C, group Y and group W135. [Specification]: Each 0.5 ml dose of reconstituted vaccine contains 50 Mug of each ...
  • Trastuzumab Injection

    Product Trastuzumab Injection

    [Dosage form]: Liquid for injection [Specification]: 150mg/vial; 440mg/vial (pipeline) 
    [Indication]: Indicated for Metastatic breast cancer, Early breast cancer, Metastatic gastric cancer. 
    [Administration]: Intravenous injection 
    [Shelf life]: 24 months
  • Adalimumab Injection

    Product Adalimumab Injection

    [Dosage form]: Liquid for injection [Specification]: 40mg/0.8ml, pre-filled syringe [Indication]: Used to treat many inflammatory conditions in adults, such as Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Ulcerative Colitis, Pl...
  • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine

    Product 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine

    [Dosage form]: Suspension for injection [Specification]: 0.5 ml/dose 
    [Indication]: Protect infants over 2 months, young children, and adults against disease caused by the bacterium Streptococcus pneumonia. 
    [Administration]: Intramuscular injection 
    [Storage temperature (℃)]: ...
  • Bevacizumab Injection

    Product Bevacizumab Injection

    English Name: Bevacizumab Injection

    Dosage Form: Liquid for injection

    Specification(Dosage): 100mg/vial; (400mg is still in pipeline)

    Indication: Indicated for Metastatic Colorectal Cancer, Advanced, Metastatic, or recurrent Non-small-cell Lung Cancer. ...

Shenzhen Mellowhope Pharm Industrial Co., Ltd. Resources (1)